White Ted's Form 4 filing
Verrica Pharmaceuticals Inc. (VRCA) · filed Jul 23, 2024
- Accession no.
- 0001415889-24-019976
- Filed
- Jul 23, 2024
- Trade date
- Jul 22-23, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $230.3K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| White TedCIK 0001741964 | Director, Officer (PRESIDENT AND CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 22, 2024 | Common Stock | SSaleDisposed | −32,469 | $7.06 | −$229,231.14 | 250,121 | Direct | |
| Jul 23, 2024 | Common Stock | SSaleDisposed | −154 | $6.98 | −$1,074.92 | 249,967 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.